SHOULDER & ELBOW
Intermittent versus continuous ropivacaine infusion and the impact on interscalene block efficacy
This report has been verified
by one or more authors of the
original publication.
Acta Anaesthesiol Scand. 2018 Jan;62(1):85-93
70 patients scheduled for major orthopaedic shoulder surgery were randomized to receive a postoperative interscalene block with ropivacaine, administered as either intermittent boluses every 2 hours or continuous infusion. Patients were assessed for pain scores, morphine use and consumption, PCA boluses administered and attempted, and adverse effects over the first 48 hours after surgery. Pain scores, morphine consumption, and PCA boluses administered and attempted did not significantly differ between the two groups. The incidence of specific adverse effects, including hoarseness and reduced cough strength, were significantly greater among patients administered intermittent boluses.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
